Azaya Therapeutics, Inc.
Industry
- Pharmaceuticals
- Drug Delivery
- Biotechnology
- Liposomes
Latest on Azaya Therapeutics, Inc.
Janssen Biotech Inc. ’s cancer medicine Doxil (doxorubicin hydrochloride liposome injection) may soon be taken off FDA’s drug shortage list following approval of Sun Pharma Global FZE ’s generic v
The Obama administration’s approach to drug shortages seems like it will closely resemble what the President’s re-election campaign will say about the economy: Let’s not focus on where we are, but foc
FDA is choosing to exercise “enforcement discretion” on imports of an unapproved version of Janssen Biotech Inc. ’s cancer drug Doxil , but is explicitly not relaxing bioequivalence standards. Dox
Summarizing the technologies of recently founded companies Showcasing recently launched companies Aeres Inc. 3125 Sterling Circle, Suite 105 Boulder, CO 80301 Phone: (303) 440-4102 Fax: (303) 440-